Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today ...

Octave Ventures, rebranded Beat Capital Partners, has received approval from Lloyd's to launch Statera Managing Agency and ...

Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round. Hikma ...

Ben Maslen and Tony Zana to be appointed to the Octave executive team as Chief Financial Officer and Chief Legal Officer & Corporate Secretary, respectively Andreas Wenzel and Thomas De Muynck to be ...

Using the TDA7052A audio amplifier to generate a five octave, linear in pitch voltage-controlled oscillator (VCO).

Hexagon has announced that the spin-off of its Asset Lifecyle Intelligence and Safety, Infrastructure & Geospatial divisions, and related businesses, will operate as Octave. Octave will be a pureplay ...